| Metric | შპს SmartPharm | შპს ფარმაცევტული სახლი + | შპს იმპექსფარმი | შპს ვიტამინი 2017 | შპს იბერიფარმა + |
|---|---|---|---|---|---|
| Growth | |||||
| Revenue | ₾32.2m₾23.8m | ₾54.7m₾40.3m | ₾108.9m₾93.3m | ₾71.2m₾49.1m | ₾7.2m₾7.1m |
| Revenue growth | 35.4% | 35.6% | 16.7% | 44.9% | 2.2% |
| Profitability | |||||
| EBITDA | ₾2.9m₾2.7m | -₾3.2m-₾930k | ₾7.7m₾6.6m | ₾4.3m₾738k | -₾778k-₾152k |
| EBITDA margin | 9.1%11.4% | -5.9%-2.3% | 7.1%7.1% | 6.0%1.5% | -10.7%-2.1% |
| Net profit | ₾2.6m₾2.4m | -₾1.6m-₾3.3m | ₾9.1m₾6.7m | ₾4.3m-₾317k | -₾778k-₾152k |
| Net margin | 8.0%10.2% | -3.0%-8.2% | 8.3%7.2% | 6.1%-0.6% | -10.7%-2.1% |
| Balance sheet | |||||
| Total assets | ₾10.8m₾8.5m | ₾38.3m₾34.8m | ₾83.9m₾72.7m | ₾10.6m₾7.3m | ₾1.6m₾1.8m |
| Total equity | ₾7.2m₾4.9m | -₾2.9m-₾1.3m | ₾58.6m₾50.1m | ₾6.2m₾2.2m | -₾1.1m-₾344k |
| ROE | 35.6%49.1% | — | 15.5%13.4% | 69.8%-14.5% | — |